Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

3,4-Diaminopyridine-d3

Product Specifications

Synonyms

3,4-DAP-d3; 3,4-Diaminopyridine-d3; 4,5-Diaminopyridine-d3; Amifampridine-d3; DAP-d3; NSC 521760-d3; Pyridine-4,5-diamine-d3; 3,4-Diamino-pyridine-d3; 3,4-Pyridinediamine-d3

Hazard Statement

Fatal if swallowed; UN number: UN2811; Packing Group: II

Purity

>95% (HPLC)

Smiles

NC1=C(N)C([2H])=NC([2H])=C1[2H]

Molecular Formula

C5H4D3N3

Molecular Weight

112.15

InChI

InChI=1S/C5H7N3/c6-4-1-2-8-3-5(4)7/h1-3H,7H2,(H2,6,8)/i1D,2D,3D

Additionnal Information

IUPAC name: pyridine-d3-3,4-diamine

Shipping Conditions

Room Temperature

Storage Conditions

-20°C

More Discoveries

Explore Other Products

Browse additional items from our catalog

Human CFAP107 Pre-designed siRNA Set A
SI002884A 1 Each

Human CFAP107 Pre-designed siRNA Set A

Sign In for Pricing
View Details
Recombinant Human CD96 protein (C-6His)
CD02077-01 10 µg

Recombinant Human CD96 protein (C-6His)

Sign In for Pricing
View Details
Recombinant Human CD96 protein (C-6His)
CD02077-02 50 µg

Recombinant Human CD96 protein (C-6His)

Sign In for Pricing
View Details
RAGE (Receptor for Advanced Glycosylation End Products, Advanced Glycosylation End Product-specific Receptor, AGER) (AP)
MBS6241908-01 0.1 mL

RAGE (Receptor for Advanced Glycosylation End Products, Advanced Glycosylation End Product-specific Receptor, AGER) (AP)

Sign In for Pricing
View Details
RAGE (Receptor for Advanced Glycosylation End Products, Advanced Glycosylation End Product-specific Receptor, AGER) (AP)
MBS6241908-02 5x 0.1 mL

RAGE (Receptor for Advanced Glycosylation End Products, Advanced Glycosylation End Product-specific Receptor, AGER) (AP)

Sign In for Pricing
View Details
P21 (Cip1, Cip-1, Cyclin-dependent Kinase Inhibitor 1A, Cip 1) (MaxLight 750) discontinued
301438-ML750 100 µL

P21 (Cip1, Cip-1, Cyclin-dependent Kinase Inhibitor 1A, Cip 1) (MaxLight 750) discontinued

Sign In for Pricing
View Details